Cocrystal Pharma Inc (COCP)
1.757
-0.05
(-2.94%)
USD |
NASDAQ |
Oct 31, 16:00
1.75
-0.01
(-0.39%)
After-Hours: 20:00
Cocrystal Pharma Enterprise Value: 0.2716M for Oct. 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2024 | 0.2716M |
| October 29, 2024 | 1.06M |
| October 28, 2024 | 0.6785M |
| October 25, 2024 | 0.2716M |
| October 24, 2024 | 1.696M |
| October 23, 2024 | 1.899M |
| October 22, 2024 | 3.222M |
| October 21, 2024 | 3.222M |
| October 18, 2024 | 2.935M |
| October 17, 2024 | 2.612M |
| October 16, 2024 | 4.239M |
| October 15, 2024 | 0.5005M |
| October 14, 2024 | 0.0681M |
| October 11, 2024 | -0.2371M |
| October 10, 2024 | -0.3389M |
| October 09, 2024 | -0.5423M |
| October 08, 2024 | -0.0336M |
| October 07, 2024 | 0.0681M |
| October 04, 2024 | 0.4242M |
| October 03, 2024 | -0.5423M |
| October 02, 2024 | -0.8475M |
| October 01, 2024 | -0.7458M |
| September 30, 2024 | -0.2371M |
| September 27, 2024 | -0.1354M |
| September 26, 2024 | -0.7458M |
| Date | Value |
|---|---|
| September 25, 2024 | -0.8475M |
| September 24, 2024 | -0.5423M |
| September 23, 2024 | 0.0681M |
| September 20, 2024 | 0.5768M |
| September 19, 2024 | -0.2371M |
| September 18, 2024 | -0.3389M |
| September 17, 2024 | -0.2371M |
| September 16, 2024 | -0.4945M |
| September 13, 2024 | -1.153M |
| September 12, 2024 | -1.051M |
| September 11, 2024 | -1.763M |
| September 10, 2024 | -0.7539M |
| September 09, 2024 | -0.6949M |
| September 06, 2024 | -0.8475M |
| September 05, 2024 | 0.0681M |
| September 04, 2024 | -0.8465M |
| September 03, 2024 | -0.6542M |
| August 30, 2024 | 0.1698M |
| August 29, 2024 | -0.9493M |
| August 28, 2024 | 0.7803M |
| August 27, 2024 | 1.086M |
| August 26, 2024 | 0.9837M |
| August 23, 2024 | 2.001M |
| August 22, 2024 | 1.086M |
| August 21, 2024 | 1.289M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-27.56M
Minimum
Dec 27 2022
132.52M
Maximum
Jan 20 2021
14.80M
Average
0.0681M
Median
Sep 05 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 482.23M |
| Alaunos Therapeutics Inc | 0.7713M |
| Oragenics Inc | 2.027M |
| Cara Therapeutics Inc | -40.77M |
| Jaguar Health Inc | 26.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.343M |
| Total Expenses (Quarterly) | 5.448M |
| EPS Diluted (Quarterly) | -0.53 |
| Earnings Yield | -101.1% |
| Normalized Earnings Yield | -122.66 |